Afters vs Aedit.
Aedit is a consumer app patients use on their own iPhone. Afters is the clinician-led visual system of record your practice runs in the consult room — on any EMR, with chart sync and a 12-month roadmap.
Sarah Jenkins
Plan #4092 • Injectables


Recommended Protocol
Neuromodulator
Forehead & Crow's Feet (50 Units)
Medical-Grade Retinol
For Sunspots (3-Month Supply)
Aedit is the stronger choice for consumers exploring procedures on their own — a free iOS app with a patented 3D AI Plastic Surgeon, medically accurate facial measurements, procedure try-ons, and an editorial library to research options before booking. Afters is the visual system of record practices use in the consult room, built around clinician-led AI simulation on any EMR, bi-directional chart sync, and a 6- and 12-month visual treatment roadmap.
How a practice-side, EMR-portable visual system of record compares to Aedit's consumer procedure-discovery app.
| Capability | Afters | Aedit |
|---|---|---|
| Who it's built for | Aesthetic practices & med spas (B2B sales tool) | Consumers researching procedures (B2C app) |
| Where it runs | In the consult room, on any device or browser | iOS app only (iPhone X+ with TrueDepth camera) |
| EMR / practice-management integration | EMR-agnostic with bi-directional chart sync | None — a standalone consumer app |
| Simulation | AI before/after on the patient's own photo | Patented 3D procedure 'try-on' from a face scan |
| Treatment-plan horizon | 6- and 12-month roadmap written to the chart | Single self-service try-on, no practice plan |
| Captures the plan for the practice | Yes — plan and simulation stay in your EMR | No — results live on the consumer's phone |
| Pricing model | Practice subscription for the visual sales layer | Free app; AEDIT PRO from $59.99/mo or $299/yr |
| Best fit | Practices wanting an in-consult visual system of record | Consumers researching procedures before a consult |
Sources: Aedit — Home · Aedit — About · Aedit — AI Plastic Surgeon (App Store) Afters product capabilities (EMR-agnostic bi-directional sync, 12-month roadmap) reflect Afters platform documentation.
We don't just "filter" faces. We simulate biological tissue response. Select a case study below to see the accuracy of our AI predictions against real follow-up photos.

Simulated Output

Accuracy Score
98.4% Match
Actual Result
The questions practices ask when comparing Afters to Aedit's consumer app.
Afters and Aedit serve different users. Aedit is a consumer iOS app for patients researching procedures on their own. Afters is the better choice for aesthetic practices that want a clinician-led visual sales tool in the consult room, with AI simulation on any EMR, bi-directional chart sync, and a 12-month treatment roadmap.
Aedit is a B2C app where consumers scan their face and try on procedures before booking. Afters is a B2B sales tool practices run during consultations; it is EMR-agnostic, writes a 6- and 12-month visual roadmap back to the patient's chart, and gives the practice a durable visual system of record.
Afters replaces the in-consult simulation and planning workflow for a practice, not Aedit's consumer discovery app. A patient may use Aedit on their own to explore options, while a practice uses Afters in the consult room to turn that interest into a planned, charted course of treatment.
Aedit is a free consumer app with an AEDIT PRO subscription from $59.99/month or $299/year, billed to patients. Afters is a practice subscription billed to the clinic, so the two are not directly comparable — they are bought by different people for different jobs.
Consumers who want to research procedures, get a facial analysis, and try on results from their own iPhone before contacting a provider are a strong fit for Aedit. Practices that need a clinician-led, chart-connected visual sales tool should use Afters.
Give your team a clinician-led visual system of record that travels with the patient chart and closes consults in the room. See what Afters adds to your practice's annual revenue.
Calculate Your Revenue Potential